Correlation Between Pulmatrix and Icosavax
Can any of the company-specific risk be diversified away by investing in both Pulmatrix and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pulmatrix and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pulmatrix and Icosavax, you can compare the effects of market volatilities on Pulmatrix and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pulmatrix with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pulmatrix and Icosavax.
Diversification Opportunities for Pulmatrix and Icosavax
Pay attention - limited upside
The 3 months correlation between Pulmatrix and Icosavax is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pulmatrix and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and Pulmatrix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pulmatrix are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of Pulmatrix i.e., Pulmatrix and Icosavax go up and down completely randomly.
Pair Corralation between Pulmatrix and Icosavax
If you would invest 686.00 in Pulmatrix on December 30, 2024 and sell it today you would earn a total of 33.00 from holding Pulmatrix or generate 4.81% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Pulmatrix vs. Icosavax
Performance |
Timeline |
Pulmatrix |
Icosavax |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Pulmatrix and Icosavax Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pulmatrix and Icosavax
The main advantage of trading using opposite Pulmatrix and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pulmatrix position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.Pulmatrix vs. Capricor Therapeutics | Pulmatrix vs. Akari Therapeutics PLC | Pulmatrix vs. Soleno Therapeutics | Pulmatrix vs. Moleculin Biotech |
Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |